Trials / Unknown
UnknownNCT05197491
Women's Menstruation During the Covid-19 Pandemic
Recognizing Menstrual Disturbance During COVID-19 Pandemic Among Obstetrics and Gynecology Healthcare Professionals, Fayoum University Hospital.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Fayoum University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The COVID-19 crisis has rapidly become the most significant public health crisis of our times. It has particularly impacted healthcare workers (HCW) due to the over-whelming of healthcare resources, as well as a critical absence of protective equipment and risk to their own health as well as the risk of exposure to their family. All these factors have likely resulted in significant levels of stress, anxiety, and affection of the general health
Detailed description
During the first wave of the pandemic, overstretched healthcare systems left health workers in hard-hit countries struggling with long working hours, fatigue, and extreme psychological stress. Rapidly vanishing supplies, national lockdown, and a feeding frenzy on the open market for personal protective equipment (PPE) led to shortages. Healthcare workers often had to care for patients with suspected or confirmed COVID-19 infection without proper training or adequate PPE. This contributed to an increased risk to healthcare workers during the initial phase of the pandemic. Study Methods: This is a retrospective cross-sectional study that will be conducted among healthcare professionals working in the obstetrics and gynecology department, Fayoum University Fayoum, Egypt. A survey-based study will be conducted between January 15 and March 1, 2022, using the database of Fayoum University. A self-administered online survey consisting of 80 questions was developed.
Conditions
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2023-08-01
- Completion
- 2023-12-01
- First posted
- 2022-01-19
- Last updated
- 2023-05-01
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05197491. Inclusion in this directory is not an endorsement.